Collective Accuryn Physiologic Signals and Signatures

Withdrawn before enrolling

Conditions studied: Critical Illness, Acute Kidney Injury, Sepsis, Septic Shock, Abdominal Compartment Syndrome

In brief

The CAPSS Study is a retrospective and prospective, multi-center, single-arm post-market data collection study with an FDA cleared device. Physiologic data measurements will be collected from enrolled subjects using electronic health records and data streams via the Accuryn Monitoring System. Analysis of these data has the potential to be able to acutely guide resuscitation and monitor trends for emerging critical conditions.

Key facts

Study ID

NCT03817281

Run by

Potrero Medical

People needed

0

Starts

2020-03-29

Expected to finish

2020-03-29

Last updated by the study team

2021-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Received Accuryn Monitoring System during hospital stay.
• Diagnosed with or developed one or more of the targeted conditions while connected to the Accuryn Monitoring System.

You may not qualify if…

• In the opinion of the investigator, the patient is unsuitable for the study.

Where it is running

• University of Washington Harborview Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.